Rubric Capital Management (New York)’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-626,929
| Closed | -$10.7M | – | 69 |
|
|
2024
Q1 | $10.7M | Hold |
626,929
| – | – | 0.32% | 55 |
|
|
2023
Q4 | $6.39M | Hold |
626,929
| – | – | 0.13% | 50 |
|
|
2023
Q3 | $5.67M | Hold |
626,929
| – | – | 0.21% | 53 |
|
|
2023
Q2 | $6.75M | Hold |
626,929
| – | – | 0.29% | 52 |
|
|
2023
Q1 | $6.41M | Hold |
626,929
| – | – | 0.17% | 60 |
|
|
2022
Q4 | $6.61M | Buy |
626,929
+67,192
| +12% | +$709K | 0.29% | 67 |
|
|
2022
Q3 | $7.18M | Buy |
559,737
+262,390
| +88% | +$3.36M | 0.36% | 57 |
|
|
2022
Q2 | $3.81M | Buy |
+297,347
| New | +$3.81M | 0.2% | 68 |
|